- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-fat bias
Total 534 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesBelgium, Luxembourg
-
Novo Nordisk A/SCompletedComparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFinland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Macedonia, The Former Yugoslav Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesHungary
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesFormer Serbia and Montenegro
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Delivery SystemsUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Denmark
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, United Kingdom, Spain, Denmark, France, Netherlands, Austria, Hungary, Russian Federation, Germany, Turkey, Italy, Bulgaria, Romania, Belgium, Switzerland, Slovenia, Czech Republic
-
Novo Nordisk A/SCompletedHealthy | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
Novo Nordisk A/SCompletedHealthy | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1United Kingdom, France, Netherlands, Belgium, Ireland
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompleted
-
Umeå UniversityCompleted
-
Umeå UniversityCompleted
-
Umeå UniversityCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesNorway, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Egypt
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIsrael
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Former Serbia and Montenegro
-
Novo Nordisk A/SCompletedObservational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin (COMMIT)Diabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovenia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Korea, Republic of